![David Eveleth](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Eveleth
Amministratore Delegato presso Trefoil Therapeutics, Inc.
Profilo
David Eveleth currently works in at least one company, Trefoil Therapeutics, Inc., where he currently holds the position of Director, Chief Executive & Financial Officer.
Posizioni attive di David Eveleth
Società | Posizione | Inizio |
---|---|---|
Trefoil Therapeutics, Inc.
![]() Trefoil Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trefoil Therapeutics, Inc. operates as a biotechnology company. The firm develops applications for the eFGFs include regenerative therapies that may address a broad range of ischemic disease, including coronary heart disease, diabetic ulcers, and peripheral artery disease. The company was founded by Ralph Bradshaw, Ken Thomas and Michael Blaber in 2013 and is headquartered in San Diego, CA. | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Trefoil Therapeutics, Inc.
![]() Trefoil Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trefoil Therapeutics, Inc. operates as a biotechnology company. The firm develops applications for the eFGFs include regenerative therapies that may address a broad range of ischemic disease, including coronary heart disease, diabetic ulcers, and peripheral artery disease. The company was founded by Ralph Bradshaw, Ken Thomas and Michael Blaber in 2013 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- David Eveleth